Systemic lupus erythematosus (SLE) is associated with multi-organ damage including cardiac valve, which may need valvular operation. However, methods for outcome prediction and prosthetic valve selection are unclear in SLE patients undergoing cardiac valve surgery.
Twenty-five SLE patients receiving valvular operation in a single institute between 2002 and 2020 were enrolled. SLICC/ACR damage index (SDI) was applied to evaluate the damage severity. Clinical outcomes were compared between patients with different SDI.
The hospital survival rate was 88%, and long-term survival rate was 59.5% and 40.2% at five and ten years. The median SDI was 4 (IQR 3–6) in our study, patients were then grouped into higher SDI (defined as SDI ≥ 5, n = 11) and lower SDI group (defined as SDI < 5, n = 14). The in-hospital survival rate (72.2% vs 100%, p = 0.074), and five-year survival rate (18.2% vs 92.9%, p < 0.001) was lower in higher SDI group, compared to lower SDI group.
SDI score was associated with long-term outcome for SLE patients receiving cardiac valve surgery. SDI ≥ 5 was associated with very poor long-term outcomes. This finding implicates that xenograft might be a reasonable choice for SLE patients with SDI ≥ 5.